echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > "DKD New Drugs" has shown its first appearance, the "Obesity Drugs" catalog has been updated, and the five major update points of the new version of the ADA Guide!

    "DKD New Drugs" has shown its first appearance, the "Obesity Drugs" catalog has been updated, and the five major update points of the new version of the ADA Guide!

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Edited by Yimaitong, please do not reprint without authorization
    .

    With the continuous emergence of new research, new technologies and new therapies, the field of diabetes diagnosis and treatment is undergoing profound changes
    .

    The American Diabetes Association (ADA) has updated its guidelines for diagnosis and treatment of diabetes every year since 1989, and has become a vane in the field of diabetes research and treatment
    .

    Recently, the "ADA Diabetes Diagnosis and Treatment Standards (2022 Edition)" (hereinafter referred to as the ADA Guidelines) was officially released.
    By comparing the 2021 version of the guidelines, Yimaitong has made an inventory of the updated points of the guidelines for your reference
    .

    (
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.